Voruciclib Uses, Dosage, Side Effects and more
Voruciclib is under investigation in clinical trial NCT03547115 (A Phase 1 Study of Voruciclib in Subjects With B-Cell Malignancies or AML).
| Trade Name | Voruciclib |
| Generic | Voruciclib |
| Voruciclib Other Names | Voruciclib |
| Type | |
| Formula | C22H19ClF3NO5 |
| Weight | Average: 469.84 Monoisotopic: 469.0903849 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
